PRESS RELEASE published on 07/06/2023 at 14:42, 1 year 4 months ago 3D screen printing technology enables fabrication of oral dosage forms with freely tailorable drug release profiles – technology and concept well suited for mass production
PRESS RELEASE published on 06/01/2023 at 14:02, 1 year 5 months ago Laxxon Medical to participate in 2023 BIO International Convention
PRESS RELEASE published on 05/31/2023 at 14:01, 1 year 5 months ago Laxxon Medical Announces Formation of Scientific Advisory Board with Renowned Pharmaceutical Experts to Support Pipeline and Life Cycle Management
PRESS RELEASE published on 04/17/2023 at 13:01, 1 year 7 months ago Laxxon Medical to Participate in 22nd Annual Needham Virtual Healthcare Conference
PRESS RELEASE published on 03/27/2023 at 14:00, 1 year 7 months ago Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
PRESS RELEASE published on 02/02/2023 at 20:15, 1 year 9 months ago Laxxon Medical to Participate in the BIO CEO & Investor Conference
PRESS RELEASE published on 01/05/2023 at 14:00, 1 year 10 months ago Laxxon Medical to Participate in 25th Annual Needham Growth Conference
Published on 11/22/2024 at 23:55, 9 hours 10 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 35 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 35 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 50 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 12 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 10 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 5 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
